Clinical Trials

Title   RTOG 0924
Principal Investigator/ Physician   Weisi Yan, MD
Protocol┬áNo.   RTOG 0924
Open Date   02/11/2014
Gender   Both
Cancer Site   Prostate
Status   Open
Contact Email   MCI Clinical Trials
Summary  

Protocol Title:  "Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial."

Inclusion Criteria: Pathologically proven diagnosis of prostatic adenocarcinoma within 180 days of registration; clinically negative lymph nodes as established by imaging within 90 days prior to registration; no evidence of bone metastases; Zubrod performance status 0-1

Exclusion Criteria: Prior invasive (except non-melanoma skin cancer) malignancy unless disease-free for 3 years; previous radical surgery (prostatectomy) or cryosurgery for prostate cancer

Clinical Trails.Gov Link:  https://clinicaltrials.gov/ct2/show/NCT01368588?term=RTOG+0924&rank=1

Email Newsletters

Connect With Us